Corrigendum to “Unveiling promising phytocompounds from Moringa oleifera as dual inhibitors of EGFR(T790M/C797S) and VEGFR-2 in non-small cell lung cancer through in silico screening, ADMET, dynamics simulation, and DFT analysis” [J. Genet. Eng. Biotechnol. 22(3) (2024) 100406]
Saved in:
| Main Authors: | Md. Masudur Rahman Munna, Md. Touki Tahamid Tusar, Saima Sajnin Shanta, Md. Hossain Ahmed, Md. Sarafat Ali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Journal of Genetic Engineering and Biotechnology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1687157X25000435 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibitory effect of 1,4,5,6-tetrahydroxy-7,8-diprenylxanthone against NSCLC with L858R/T790M/C797S mutant EGFR
by: Jing Wang, et al.
Published: (2024-11-01) -
Advanced lung adenocarcinoma harboring uncommon EGFR 19 Del and T790M/trans-C797S mutations after resistance: a case report and literature review
by: Yuting Xiao, et al.
Published: (2025-04-01) -
Design and synthesis of quinoxaline-piperazine-pyrazolo conjugates as VEGFR-2 targeting agents and ADMET studies
by: Basupally Srinivas, et al.
Published: (2025-07-01) -
Triplet therapy overcomes 3rd-EGFR TKI-resistant EGFR-L858R/T790M/C797S in trans and in cis/L718Q mutation
by: Kaibo Ding, et al.
Published: (2025-03-01) -
EngMedicine: A community of engineering and medicine
by: Gao-Jun Teng, MD
Published: (2024-06-01)